JPRN-UMIN000009927
Completed
Phase 2
Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myeloma - Immunomoduratory activity for MM treated with lenalidomide
Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University0 sites33 target enrollmentFebruary 1, 2013
Conditionsplasma cell myeloma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- plasma cell myeloma
- Sponsor
- Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) previously administered lenalidomide 2\) hypersensitive reaction for lenalidomide, thalidomide and dexamethazone 3\) non\-secretory myeloma, solitary plasmacytoma, plasmacell leukemia and POEMS syndrome 4\) CTCAE more than grade 3 neutropenia, thrombocytopenia 5\) HBsAg is positive 6\) HCV is positive, HIV is positive 7\) uncontrollable liver dysfunction, renal insufficiency, cardiac dysfunction, respiratory dysfunction, diabetus mellitus, hypertension and infection 8\) double cancer 9\) psychoneurotic disorder, depression state or history 10\) pregnant female, possible pregnancy or durling lactation 11\) pulomonary fibrosis and interstitial pneumonitis interstitial shadow on chest CT, even if no sympton 12\) physicians' decision
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level studyCTRI/2020/06/025861Department of Ayush Uttarakhand
Recruiting
Phase 3
Evaluation of therapeutic effects of Crocina in knee osteoarthritisosteoarthritis.Primary osteoarthritis of other jointsM19.0IRCT20190419043318N1Bojnourd University of Medical Sciences60
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
Completed
Not Applicable
Verification on the immunomodulatory effects of continuous consumption of dairy productsHealthy adultJPRN-UMIN000053187Meiji Co., Ltd140
Completed
Phase 4
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16